002219 Stock Overview
Engages in the provision of medical services and pharmaceuticals products in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
New Journey Health Technology Group Co.,LTD Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥2.76 |
| 52 Week High | CN¥3.36 |
| 52 Week Low | CN¥1.66 |
| Beta | 0.43 |
| 11 Month Change | 9.52% |
| 3 Month Change | 62.35% |
| 1 Year Change | -16.36% |
| 33 Year Change | -23.33% |
| 5 Year Change | 20.00% |
| Change since IPO | 59.73% |
Recent News & Updates
Some May Be Optimistic About New Journey Health Technology GroupLTD's (SZSE:002219) Earnings
Nov 04
New Journey Health Technology Group Co.,LTD (SZSE:002219) Stock Rockets 36% As Investors Are Less Pessimistic Than Expected
Oct 25Is New Journey Health Technology GroupLTD (SZSE:002219) Using Too Much Debt?
Oct 18Returns On Capital Are Showing Encouraging Signs At New Journey Health Technology GroupLTD (SZSE:002219)
Sep 30Recent updates
Some May Be Optimistic About New Journey Health Technology GroupLTD's (SZSE:002219) Earnings
Nov 04New Journey Health Technology Group Co.,LTD (SZSE:002219) Stock Rockets 36% As Investors Are Less Pessimistic Than Expected
Oct 25Is New Journey Health Technology GroupLTD (SZSE:002219) Using Too Much Debt?
Oct 18Returns On Capital Are Showing Encouraging Signs At New Journey Health Technology GroupLTD (SZSE:002219)
Sep 30Pinning Down New Journey Health Technology Group Co.,LTD's (SZSE:002219) P/S Is Difficult Right Now
Sep 10New Journey Health Technology GroupLTD (SZSE:002219) Has A Somewhat Strained Balance Sheet
Jun 24Returns At New Journey Health Technology GroupLTD (SZSE:002219) Are On The Way Up
Jun 07What New Journey Health Technology Group Co.,LTD's (SZSE:002219) P/S Is Not Telling You
May 14New Journey Health Technology GroupLTD's (SZSE:002219) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 24Shareholder Returns
| 002219 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | -2.1% | -2.9% | -3.4% |
| 1Y | -16.4% | -12.7% | 6.1% |
Return vs Industry: 002219 underperformed the CN Healthcare industry which returned -12.7% over the past year.
Return vs Market: 002219 underperformed the CN Market which returned 6.1% over the past year.
Price Volatility
| 002219 volatility | |
|---|---|
| 002219 Average Weekly Movement | 9.2% |
| Healthcare Industry Average Movement | 8.6% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 002219 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002219's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 7,803 | n/a | www.njhtg.com |
New Journey Health Technology Group Co.,LTD, together with its subsidiaries, engages in the provision of medical services and pharmaceuticals products in China and internationally. It operates regional medical centers, and tertiary and second-level hospitals. The company is also involved in the research and development, production, and sale of pharmaceutical products, including Duyiwei capsules and tablets, Shenqi Wuweizi tablets, Maiping tablets, Qianlie Antong tablets, and Gongliuning capsules.
New Journey Health Technology Group Co.,LTD Fundamentals Summary
| 002219 fundamental statistics | |
|---|---|
| Market cap | CN¥9.38b |
| Earnings (TTM) | CN¥50.15m |
| Revenue (TTM) | CN¥3.76b |
187.0x
P/E Ratio2.5x
P/S RatioIs 002219 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002219 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.76b |
| Cost of Revenue | CN¥2.68b |
| Gross Profit | CN¥1.08b |
| Other Expenses | CN¥1.03b |
| Earnings | CN¥50.15m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.015 |
| Gross Margin | 28.77% |
| Net Profit Margin | 1.33% |
| Debt/Equity Ratio | 67.7% |
How did 002219 perform over the long term?
See historical performance and comparison